|
---|
血管生成素 |
- 激酶抑制劑:Altiratinib
- CE-245677
- Rebastinib
- 抗體: Evinacumab (against angiopoietin 3)
- 奈伐库单抗 (against angiopoietin 2)
|
---|
CNTF |
- 受體激動劑:Axokine
- CNTF
- Dapiclermin
|
---|
EGF(ErbB)
| 表皮生长因子受体 (EGF(ErbB1/HER1))
|
- 受體激動劑:Amphiregulin
- Betacellulin
- EGF(尿抑腸素)
- Epigen
- Epiregulin
- 人類肝素結合表皮生長因子(HB-EGF)
- Murodermin
- Nepidermin
- 转化生长因子-α(TGFα)
- 激酶抑制劑:阿法替尼
- AG-490
- Agerafenib
- Brigatinib
- Canertinib
- 达可替尼
- 厄洛替尼
- 吉非替尼
- Grandinin
- Icotinib
- 拉帕替尼
- Neratinib
- 奥希替尼
- Vandetanib
- WHI-P 154
- 抗體: 西妥昔單抗
- Depatuxizumab
- Depatuxizumab mafodotin
- 伏妥昔单抗
- 英加妥珠单抗
- Matuzumab
- 耐昔妥珠单抗
- Nimotuzumab
- Panitumumab
- Zalutumumab
|
---|
ErbB2/HER2 |
- 激酶抑制劑:阿法替尼
- AG-490
- 拉帕替尼
- Mubritinib
- Neratinib
|
---|
ErbB3/HER3 |
- 受體激動劑:Neuregulins (heregulins) (1, 2, 6 (neuroglycan C))
|
---|
ErbB4/HER4 |
- 受體激動劑:Betacellulin
- Epigen
- Heparin-binding EGF-like growth factor (HB-EGF)
- Neuregulins (heregulins) (1, 2, 3, 4, 5 (tomoregulin, TMEFF))
|
---|
|
---|
FGF | FGFR1 |
- 受體激動劑:Ersofermin
- FGF (1, 2 (bFGF), 3, 4, 5, 6, 8, 10 (KGF2), 20)
- Repifermin
- Trafermin
- Velafermin
|
---|
FGFR2 |
- 受體激動劑:Ersofermin
- FGF (1, 2 (bFGF), 3, 4, 5, 6, 7 (KGF), 8, 9, 10 (KGF2), 17, 18, 22)
- Palifermin
- Repifermin
- Sprifermin
- Trafermin
- 抗體: Aprutumab
- Aprutumab ixadotin
|
---|
FGFR3 |
- 受體激動劑:Ersofermin
- FGF (1, 2 (bFGF), 4, 8, 9, 18, 23)
- Sprifermin
- Trafermin
- 抗體: Burosumab (against FGF23)
|
---|
FGFR4 |
- 受體激動劑:Ersofermin
- FGF (1, 2 (bFGF), 4, 6, 8, 9, 19)
- Trafermin
|
---|
Unsorted | |
---|
|
---|
HGF (c-Met) |
- 受體激動劑:Hepatocyte growth factor
- Potentiators: Dihexa (PNB-0408)
- 激酶抑制劑:Altiratinib
- AM7
- AMG-458
- Amuvatinib
- BMS-777607
- Cabozantinib
- Crizotinib
- Foretinib
- Golvatinib
- INCB28060
- JNJ-38877605
- K252a
- MK-2461
- PF-04217903
- PF-2341066
- PHA-665752
- SU-11274
- Tivantinib
- Volitinib
|
---|
IGF | IGF-1 |
- 受體激動劑:des(1-3)IGF-1
- 胰岛素样生长因子1(生長調節素C)
- IGF-1 LR3
- Insulin-like growth factor-2 (somatomedin A)
- Insulin
- Mecasermin
- Mecasermin rinfabate
- 激酶抑制劑:BMS-754807
- Linsitinib
- NVP-ADW742
- NVP-AEW541
- OSl-906
- 抗體: AVE-1642
- Cixutumumab
- Dalotuzumab
- 芬妥木单抗
- 加尼妥单抗
- 罗妥木单抗
- R1507
- Teprotumumab
- Xentuzumab (against IGF-1 and IGF-2)
|
---|
IGF-2 |
- 受體激動劑:Insulin-like growth factor-2 (somatomedin A)
- 抗體: 度司妥单抗
- Xentuzumab (against IGF-1 and IGF-2)
|
---|
其他 |
- Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7)
- Cleavage products/derivatives with unknown target: Glypromate (GPE, (1-3)IGF-1)
- 曲非奈肽
|
---|
|
---|
LNGF (p75NTR) |
- 受體激動劑:BDNF
- BNN-20
- BNN-27
- Cenegermin
- DHEA
- DHEA-S
- NGF
- NT-3
- NT-4
- 受體拮抗劑:ALE-0540
- 地塞米松
- EVT-901 (SAR-127963)
- 睾酮
- 抗體: 抗NGF: ABT-110 (PG110)
- ASP-6294
- 法司努单抗
- Frunevetmab
- Fulranumab
- MEDI-578
- Ranevetmab
- 他尼珠单抗
- Aptamers: Against NGF: RBM-004
|
---|
PDGF |
- 受體激動劑:Becaplermin
- PDGF(A, B, C, D)
- 激酶抑制劑:Agerafenib
- Axitinib
- Crenolanib
- 伊马替尼
- Lenvatinib
- 马赛替尼
- Motesanib
- 尼達尼布
- Pazopanib
- Radotinib
- Quizartinib
- 舒尼替尼
- 索拉非尼
- Toceranib
- 抗體: Olaratumab
- Ramucirumab
- Tovetumab
|
---|
RET (GFL) | GFRα1 |
- 受體激動劑:Glial cell line-derived neurotrophic factor (GDNF)
- Liatermin
|
---|
GFRα2 | |
---|
GFRα3 | |
---|
GFRα4 | |
---|
Unsorted | |
---|
|
---|
SCF (c-Kit) |
- 受體激動劑:Ancestim
- Stem cell factor
|
---|
TGFβ | |
---|
Trk | TrkA |
- 受體激動劑:Amitriptyline
- BNN-20
- BNN-27
- Cenegermin
- DHEA
- DHEA-S
- Gambogic amide
- NGF
- Tavilermide
- Negative allosteric modulators: VM-902A
- 激酶抑制劑:Altiratinib
- AZD-6918
- CE-245677
- CH-7057288
- DS-6051
- Entrectinib
- GZ-389988
- K252a
- Larotrectinib
- Lestaurtinib
- Milciclib
- ONO-4474
- ONO-5390556
- PLX-7486
- Rebastinib
- SNA-120 (pegylated K252a))
- 抗體: Against TrkA: GBR-900; Against NGF: ABT-110 (PG110)
- ASP-6294
- 法司努单抗
- Frunevetmab
- Fulranumab
- MEDI-578
- Ranevetmab
- Tanezumab
- Aptamers: Against NGF: RBM-004
|
---|
TrkB |
- 受體激動劑:3,7-DHF
- 3,7,8,2'-THF
- 4'-DMA-7,8-DHF
- 7,3'-DHF
- 7,8-DHF
- 7,8,2'-THF
- 7,8,3'-THF
- 阿米替林
- BDNF
- BNN-20
- Deoxygedunin
- Deprenyl
- Diosmetin
- DMAQ-B1
- HIOC
- LM22A-4
- N-乙酰血清素
- NT-3
- NT-4
- Norwogonin (5,7,8-THF)
- R7
- TDP6
- 受體拮抗劑:ANA-12
- Cyclotraxin B
- Gossypetin (3,5,7,8,3',4'-HHF)
- 激酶抑制劑:Altiratinib
- AZD-6918
- CE-245677
- CH-7057288
- DS-6051
- Entrectinib
- GZ-389988
- K252a
- Larotrectinib
- Lestaurtinib
- ONO-4474
- ONO-5390556
- PLX-7486
|
---|
TrkC |
- 激酶抑制劑:Altiratinib
- AZD-6918
- CE-245677
- CH-7057288
- DS-6051
- Entrectinib
- GZ-389988
- K252a
- Larotrectinib
- Lestaurtinib
- ONO-4474
- ONO-5390556
- PLX-7486
|
---|
|
---|
VEGF |
- 受體激動劑:Placental growth factor (PGF)
- Telbermin
- VEGF (A, B, C, D (FIGF))
- Allosteric modulators: Cyclotraxin B
- 激酶抑制劑:Agerafenib
- Altiratinib
- Axitinib
- Cabozantinib
- Cediranib
- 拉帕替尼
- Lenvatinib
- Motesanib
- 尼達尼布
- Pazopanib
- Pegaptanib
- Rebastinib
- Regorafenib
- Semaxanib
- 索拉非尼
- 舒尼替尼
- Toceranib
- Tivozanib
- Vandetanib
- WHI-P 154
|
---|
其他 |
- Additional growth factors: Adrenomedullin
- Colony-stimulating factors (see here instead)
- Connective tissue growth factor (CTGF)
- Ephrins (A1, A2, A3, A4, A5, B1, B2, B3)
- 紅血球生成素 (see here instead)
- 葡萄糖-6-磷酸異構酶(GPI; PGI, PHI, AMF)
- Glia maturation factor (GMF)
- Hepatoma-derived growth factor (HDGF)
- 白细胞介素/T-cell growth factors (see here instead)
- 白血病抑制因子(LIF)
- Macrophage-stimulating protein (MSP; HLP, HGFLP)
- Midkine (NEGF2)
- Migration-stimulating factor (MSF; PRG4)
- Oncomodulin
- Pituitary adenylate cyclase-activating peptide (PACAP)
- Pleiotrophin
- Renalase
- 促血小板生成素 (see here instead)
- Wnt信号通路
- Additional growth factor receptor modulators: Cerebrolysin (neurotrophin mixture)
|
---|
|